{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:13:14Z","timestamp":1776291194112,"version":"3.50.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140565","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T18:06:24Z","timestamp":1445018784000},"page":"e0140565","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Wen","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"S Franks","year":"1995","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/09513590903247873","article-title":"An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome","volume":"26","author":"D Glintborg","year":"2010","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2009.05.010","article-title":"Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment","volume":"19","author":"G Garruti","year":"2009","journal-title":"Reproductive biomedicine online"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"S Kirchengast","year":"2001","journal-title":"Human reproduction (Oxford, England)"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the Androgen Excess Society","volume":"92","author":"KE Salley","year":"2007","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9468","key":"ref6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"RH Eckel","year":"2005","journal-title":"Lancet"},{"issue":"21","key":"ref7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"HM Lakka","year":"2002","journal-title":"Jama"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"P Libby","year":"2002","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4614-0650-1_5","article-title":"Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity","volume":"721","author":"F Samad","year":"2011","journal-title":"Advances in experimental medicine and biology"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"N Ouchi","year":"2011","journal-title":"Nature reviews Immunology"},{"issue":"36","key":"ref11","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.2174\/092986710794183006","article-title":"Inflammation, adiponectin, obesity and cardiovascular risk","volume":"17","author":"H Mangge","year":"2010","journal-title":"Current medicinal chemistry"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"KA Toulis","year":"2009","journal-title":"Human reproduction update"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"KA Toulis","year":"2011","journal-title":"Human reproduction update"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"S Li","year":"2009","journal-title":"Jama"},{"issue":"6818","key":"ref15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"CM Steppan","year":"2001","journal-title":"Nature"},{"issue":"5708","key":"ref16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"A Fukuhara","year":"2005","journal-title":"Science (New York, NY)"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/2141-9248.113660","article-title":"Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone","volume":"3","author":"J Chakrabarti","year":"2013","journal-title":"Annals of medical and health sciences research"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.fertnstert.2011.04.073","article-title":"Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome","volume":"96","author":"R Yildizhan","year":"2011","journal-title":"Fertility and sterility"},{"issue":"1","key":"ref19","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"M Costello","year":"2007","journal-title":"The Cochrane database of systematic reviews"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertility and sterility"},{"issue":"1","key":"ref21","first-page":"1","article-title":"Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines","volume":"56","author":"E Carmina","year":"2004","journal-title":"Minerva ginecologica"},{"issue":"4","key":"ref22","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"N Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Statistics in medicine"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled clinical trials"},{"issue":"7414","key":"ref25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/09513590.2014.975684","article-title":"The impact of metformin treatment on adiponectin and resistin levels in women with polycystic ovary syndrome: a prospective clinical study","volume":"31","author":"G Basios","year":"2015","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"K Elkind-Hirsch","year":"2008","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/jog.12101","article-title":"Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome","volume":"39","author":"HO Hamed","year":"2013","journal-title":"The journal of obstetrics and gynaecology research"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/09513590802128968","article-title":"Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment","volume":"24","author":"J Jakubowska","year":"2008","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/eje.0.1440509","article-title":"Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome","volume":"144","author":"I Kowalska","year":"2001","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"1","key":"ref31","first-page":"2","article-title":"Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)\u2014the effect of metformin treatment","volume":"65","author":"A Kruszynska","year":"2014","journal-title":"Endokrynologia Polska"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/oby.2008.491","article-title":"Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients","volume":"17","author":"M Luque-Ramirez","year":"2009","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"GA Maciel","year":"2004","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2478\/v10042-009-0032-0","article-title":"Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations\u2014introductory report","volume":"47","author":"A Marciniak","year":"2009","journal-title":"Folia histochemica et cytobiologica \/ Polish Academy of Sciences, Polish Histochemical and Cytochemical Society"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03345790","article-title":"Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention","volume":"33","author":"LJ Moran","year":"2010","journal-title":"Journal of endocrinological investigation"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"L Morin-Papunen","year":"2003","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jcem.83.7.4944","article-title":"Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome","volume":"83","author":"LC Morin-Papunen","year":"1998","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"EH Ng","year":"2001","journal-title":"Human reproduction (Oxford, England)"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2478\/v10153-011-0052-3","article-title":"Effect of short-term standard therapeutic regimens on neuropeptide Y and adipose tissue hormones in overweight insulin-resistant women with polycystic ovary syndrome","volume":"53","author":"MM Orbetzova","year":"2011","journal-title":"Folia medica"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2008.10.058","article-title":"Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome","volume":"93","author":"M Ozkaya","year":"2010","journal-title":"Fertility and sterility"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.fertnstert.2007.05.004","article-title":"Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome","volume":"89","author":"D Romualdi","year":"2008","journal-title":"Fertility and sterility"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/193229680700100212","article-title":"Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome","volume":"1","author":"CA Steiner","year":"2007","journal-title":"Journal of diabetes science and technology"},{"issue":"4","key":"ref43","first-page":"272","article-title":"Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome","volume":"21","author":"I Tarkun","year":"2010","journal-title":"European cytokine network"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.injury.2006.02.001","article-title":"Grading the evidence: levels of evidence and grades of recommendation","volume":"37","author":"BA Petrisor","year":"2006","journal-title":"Injury"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"e95794","DOI":"10.1371\/journal.pone.0095794","article-title":"The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis","volume":"9","author":"X Niu","year":"2014","journal-title":"PloS one"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"A Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"J Puurunen","year":"2011","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jc.2003-031720","article-title":"Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"89","author":"S Taponen","year":"2004","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"e81190","DOI":"10.1371\/journal.pone.0081190","article-title":"Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history","volume":"8","author":"D Wang","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"e92995","DOI":"10.1371\/journal.pone.0092995","article-title":"Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index","volume":"9","author":"M Manco","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566524053766022","article-title":"Insulin resistance in type 2 diabetes\u2014role of the adipokines","volume":"5","author":"P Arner","year":"2005","journal-title":"Current molecular medicine"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/diabetes.55.02.06.db05-1064","article-title":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase","volume":"55","author":"BJ Davis","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"T Kadowaki","year":"2006","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls","volume":"155","author":"D Glintborg","year":"2006","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"e48643","DOI":"10.1371\/journal.pone.0048643","article-title":"Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation","volume":"7","author":"JS Marino","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000350217","article-title":"Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome","volume":"75","author":"YE Jeon","year":"2013","journal-title":"Gynecologic and obstetric investigation"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.fertnstert.2011.02.041","article-title":"Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome","volume":"95","author":"SB Lecke","year":"2011","journal-title":"Fertility and sterility"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpag.2012.09.002","article-title":"Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome","volume":"26","author":"T Kale-Gurbuz","year":"2013","journal-title":"Journal of pediatric and adolescent gynecology"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"e15503","DOI":"10.5812\/ijem.15503","article-title":"Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome","volume":"12","author":"F Farshchian","year":"2014","journal-title":"International journal of endocrinology and metabolism"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09513590802653833","article-title":"Serum resistin and adiponectin levels in women with polycystic ovary syndrome","volume":"25","author":"M Yilmaz","year":"2009","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2006-0361","article-title":"Reduced plasma visfatin\/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans","volume":"91","author":"C Pagano","year":"2006","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"8","key":"ref62","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"LR Harborne","year":"2005","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"S Tan","year":"2007","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"RS Legro","year":"2007","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/humrep\/deh013","article-title":"Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome?","volume":"19","author":"F Orio Jr.","year":"2004","journal-title":"Human reproduction"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","article-title":"Serum adiponectin levels in women with polycystic ovary syndrome","volume":"18","author":"D Panidis","year":"2003","journal-title":"Human reproduction"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ijo.0801996","article-title":"Human leptin locus (LEP) alleles and BMI in Samoans","volume":"26","author":"ST McGarvey","year":"2002","journal-title":"International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity"},{"issue":"11","key":"ref68","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"SE Kahn","year":"1993","journal-title":"Diabetes"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.fertnstert.2008.06.045","article-title":"Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"92","author":"KA Toulis","year":"2009","journal-title":"Fertility and sterility"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T16:51:36Z","timestamp":1567270296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140565"}},"subtitle":[],"editor":[{"given":"Susanne","family":"Kaser","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}